Candidate/environment: He became interested in an academic career while in medical school. His senior project examining radiation treatment in Hodgkin's disease was recognized as the most outstanding original pediatric research. During residency training, his interest focused to gastroenterology, specifically the pathogenesis of inflammatory bowel disease (IBD). For this reason, he accepted a fellowship position at Children's Memorial Hospital. He examined various avenues of research, choosing Dr. Terrence Barrett, a NIH-funded mucosal immunologist, to mentor his training in intestinal immunology. Over the past 2.5 years, he has developed a sincere enthusiasm to continue his career as a physician-scientist and investigate IBD. The mentor has a strong laboratory environment for support with PhD's specializing in molecular biology, microbiology, and immunology. Dr. Stephen Miller is serving as co-mentor for this application, making available the entire resources of his lab and the resources of the Department of Immunobiology at Northwestern University. His immediate career goal is to obtain funding to protect a majority of his time to continue to develop the proposed studies in this application, facilitating intellectual development as well as novel ideas and data that can be used to generate future independent funding. This protected time will allow him to make the commitment necessary to be a successful clinician-scientist. Research: Pathways controlling T cell trafficking to the colon are essential to the pathogenesis of human IBD, but poorly understood. This proposal focuses on a pathway of effector T cell recruitment to the colon. It initially focuses on characterizing the recruitment for P-selectin glycoprotein ligand (PSGL) 1 as a T cell marker for direct effector cells to the colon. More importantly, the requirement for this pathway will be studied in an experimental model of Th1-mediated colitis (IL-10 knockout mice) and a pathogen-induced Th1-mediated model of colitis in which the pathogen has been manipulated to aloe for examination of antigen-specific recruitment. The ultimate goal is that these principles will help to understand the pathogenesis of human IBD and provide potential targets for therapy. This award will facilitate his transition to an independent research career. He has the commitment of the University and Division to transfer novel observations and data from this proposal into his into his own lab during the 4th year. During the final two years, technical and lab support will be provided to aid his generation of a proposal for independent funding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08DK066161-01A1
Application #
6869211
Study Section
Special Emphasis Panel (ZDK1-GRB-N (O5))
Program Officer
Podskalny, Judith M,
Project Start
2005-07-01
Project End
2010-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$129,060
Indirect Cost
Name
Children's Memorial Hospital (Chicago)
Department
Type
DUNS #
074438755
City
Chicago
State
IL
Country
United States
Zip Code
60611
Cohran, Valeria; Managlia, Elizabeth; Bradford, Emily M et al. (2016) Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal Resection. Am J Pathol 186:1837-1846
Brown, Jeffrey B; Cheresh, Paul; Zhang, Zheng et al. (2012) P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis. Inflamm Bowel Dis 18:323-32
Brown, Jeffrey B; Cheresh, Paul; Goretsky, Tatiana et al. (2011) Epithelial phosphatidylinositol-3-kinase signaling is required for ýý-catenin activation and host defense against Citrobacter rodentium infection. Infect Immun 79:1863-72
Lee, Goo; Goretsky, Tatiana; Managlia, Elizabeth et al. (2010) Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology 139:869-81, 881.e1-9
Brown, Jeffrey B; Lee, Goo; Managlia, Elizabeth et al. (2010) Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Gastroenterology 138:595-605, 605.e1-3
George, Robert J; Sturmoski, Mark A; May, Randal et al. (2009) Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury. Am J Physiol Gastrointest Liver Physiol 296:G245-54
Sureban, Sripathi M; May, Randal; Ramalingam, Satish et al. (2009) Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology 137:649-59, 659.e1-2
Sureban, Sripathi M; May, Randal; George, Robert J et al. (2008) Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology 134:1448-58
May, Randal; Riehl, Terrence E; Hunt, Clayton et al. (2008) Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 26:630-7
Brown, Jeffrey B; Lee, Goo; Grimm, Gery R et al. (2008) Therapeutic benefit of pentostatin in severe IL-10-/- colitis. Inflamm Bowel Dis 14:880-7

Showing the most recent 10 out of 12 publications